Updates on the pathogenicity status of Pseudomonas aeruginosa

MW Azam, AU Khan - Drug discovery today, 2019 - Elsevier
Drug discovery today, 2019Elsevier
Highlights•MDR P. aeruginosa is one of the major causes of the nosocomial
infections.•Virulence factors involved in pathogenicity were described.•Potential inhibitors of
P. aeruginosa virulence factors were discussed.•The influence of QS on CRISPR-Cas
system was also discussed.Pseudomonas aeruginosa is a pathogenic bacterial species that
causes infections and diseases in both plants and animals, including several human
diseases, especially in immune-compromised patients, and many hospital-acquired …
Highlights
  • MDR P. aeruginosa is one of the major causes of the nosocomial infections.
  • Virulence factors involved in pathogenicity were described.
  • Potential inhibitors of P. aeruginosa virulence factors were discussed.
  • The influence of QS on CRISPR-Cas system was also discussed.
Pseudomonas aeruginosa is a pathogenic bacterial species that causes infections and diseases in both plants and animals, including several human diseases, especially in immune-compromised patients, and many hospital-acquired infections. Given that P. aeruginosa is an opportunistic pathogen, the occurrence of antimicrobial resistance makes it difficult to treat and eradicate. Antimicrobial resistance in P. aeruginosa is categorized as intrinsic, acquired, or adaptive. Here, we different aspects of resistance and pathogenicity in P. aeruginosa, such as the role of outer membrane proteins, transcriptional regulators, efflux pumps, enzymes, and biofilms in antimicrobial resistance. We also highlight quorum-sensing (QS) genes, their protein secretion, and role in pathogenicity; different QS inhibitors; and the influence of QS on the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system and virulence factor production.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果